COVID-19 reinfection in a patient receiving immunosuppressive treatment for antineutrophil cytoplasmic antibody-associated vasculitis

File(s)

COVID-19 Reinfection in a Patient Receiving Immunosuppressive Treatment for Antineutrophil Cytoplasmic Antibody-Associated V.pdf (1.31 MB)

Accepted version

Show more

Author(s)

Gulati, Kavita

Prendecki, Maria

Clarke, Candice

Willicombe, Michelle

McAdoo, Stephen

Type

Journal Article

Date Issued

2021-06

Date Acceptance

2021-01-08

Citation

Arthritis and Rheumatology, 2021, 73 (6), pp.1091-1092

URI

http://hdl.handle.net/10044/1/89305

URL

https://onlinelibrary.wiley.com/doi/10.1002/art.41671

DOI

https://www.dx.doi.org/10.1002/art.41671

ISSN

0004-3591

Publisher

Wiley

Start Page

1091

End Page

1092

Journal / Book Title

Arthritis and Rheumatology

Volume

73

Issue

6

Copyright Statement

© 2021, American College of Rheumatology. This is the accepted version of the following article: Gulati, K., Prendecki, M., Clarke, C., Willicombe, M. and McAdoo, S. (2021), COVID-19 Reinfection in a Patient Receiving Immunosuppressive Treatment for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Arthritis Rheumatol, 73: 1091-1092, which has been published in final form at https://doi.org/10.1002/art.41671

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000636613800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Rheumatology

Publication Status

Published

Date Publish Online

2021-01-29